Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Cryogenic Solutions Inc. (CYGS) -- Ignore unavailable to you. Want to Upgrade?

To: Janice Shell who wrote (1304)	7/20/1998 3:30:00 PM
From: Big Dog	Read Replies (1) \| Respond to of 4028

Janice, you lose. Look at CYGS now. BIG DOG

To: Janice Shell who wrote (1304)	7/20/1998 3:32:00 PM
From: Cavalry	Read Replies (1) \| Respond to of 4028

Please explain to me how you destroyed all your credibility on SI Cav

To: Janice Shell who wrote (1304)	7/20/1998 3:33:00 PM
From: Due Diligence	Respond to of 4028

Janice: Keep posting, It's really helping the price to UT the last 1/2 hour.<chuckle> Jimbo

To: Janice Shell who wrote (1304)	7/20/1998 3:35:00 PM
From: Big Dog	Read Replies (1) \| Respond to of 4028

Please Janice, bash us a little more. We need the price up. Ha BIG DOG

To: Janice Shell who wrote (1304)	7/20/1998 3:49:00 PM
From: Graham Marshman	Respond to of 4028

Janice, Without this or a similar provision the clinic would be restricted to Costa Rica nationals only. Graham

To: Janice Shell who wrote (1304)	7/20/1998 5:15:00 PM
From: Janice Shell	Read Replies (1) \| Respond to of 4028

wasn't cygs who said buy 5000 shares of their stock get first in line for cancer treatment, it was a hospital they leased their technology to that did this. An addendum: sure was: Cryogenic Solutions Inc. Licenses TeloVector Technology to Costa Rican Clinic Business Wire - January 05, 1998 18:27 %CRYOGENIC-SOLUTIONS CYGS %TEXAS %BIOTECHNOLOGY %MEDICINE V%BW P%BW HOUSTON--(BUSINESS WIRE)--Jan. 5, 1998-- Mike Skillern, newly appointed president of Cryogenic Solutions Inc. (OTC BB:CYGS), announced that CSI has agreed to license its TeloVector(TM) technology to Clinica Lirpa, S.A. of Costa Rica. Clinica Lirpa, S.A. is especially interested in the gerontology (anti-aging) and oncology (anti-cancer) applications of the TeloVector. The license agreement will permit Clinica Lirpa, Ltd. to utilize the company's ssDNA vector technology for research, trial, and commercial purposes in Costa Rica. Clinica Lirpa will be responsible for all regulatory compliance and approval in Costa Rica as a term of the agreement. As a condition of the license agreement, Clinica Lirpa, has agreed to "preferential access" for anyone owning 5,000 or more shares of CSI common stock as of March 1, 1998. "Essentially, Clinica Lirpa will confirm reservations to qualified individuals with at least 5,000 shares registered in their name," said Skillern. "Everyone else will be served on a space available basis. This preferential access will be for all services offered by Clinica Lirpa, not just services developed from our TeloVector(TM)." In April 1997, the company acquired technology and began perfecting the patent for their TeloVector(TM) which can synthesize single strands of DNA (ssDNA) inside cells to repair telomere ends shortened during cell division (mitosis). "Hopefully, history will show 1997 as a groundwork year, and 1998 as our breakthrough year for real progress," said chairman Dell Gibson. "We are planning a series of announcements throughout the first quarter of 1998 now that our telomeric ssDNA vector cassette is ready for cell studies." Clinica Lirpa spokesman, Jorge Castro Olmos expressed full confidence in the potential of the TeloVector(TM) technology. "We are pleased to be the first medical facility that will offer the therapies the ssDNA vector will provide, and we're looking forward to demonstrating the full range of possibilities." - CONTACT: Cryogenic Solutions Inc., Houston Dell Gibson, 713/780-1399 email: cygs@wt.net website: biogenix.com techstocks.com Utter slime.